Nearly 100% Horizontal Dipole Orientation and Upconversion Efficiency in Blue Thermally Activated Delayed Fluorescent Emitters

The relationship between anisotropic orientation and molecular structure of thermally activated delayed fluorescent (TADF)‐based organic light emitting devices (OLEDs) is studied using TADF emitters with carbazole, biscarbazole, and triscarbazole donor units. The bicarbazole and triscarbazole donors are more effective than the carbazole donor in driving the anisotropic orientation of the TADF molecules. A near‐perfect in‐plane orientation of the TADF dipole moment is demonstrated using the triscarbazole donor. In addition, the triscarbazole donor based OLED shows high photoluminescence quantum yield and an upconversion efficiency close to 100%. As a consequence, an external quantum efficiency >30% is obtained.A systematic study correlating donor structure with horizontal dipole orientation of blue triscarbazole thermally activated delayed fluorescent (TADF) emitters shows an exceptionally high horizontal dipole orientation of 95%. The dipole orientation and high photoluminescence quantum yield result in an external quantum efficiency >30% in organic light‐emitting diodes employing these TADF emitters.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/145231/1/adom201701340.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/145231/2/adom201701340_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/145231/3/adom201701340-sup-0001-S1.pd

Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea

Background/AimsAccurately diagnosing inflammatory bowel disease (IBD) remains a challenge, but is crucial for providing proper management for affected patients. The aim of the present study was to evaluate the frequency of change in diagnosis in Korean patients who were referred to our institution with a diagnosis of IBD.MethodsWe enrolled 1,444 patients diagnosed with ulcerative colitis (UC) and 1,452 diagnosed with Crohn's disease (CD), who had been referred to the Asan Medical Center between January 2010 and December 2014. These patients were assessed and subsequently classified as having UC, CD, indeterminate colitis, possible IBD, or non-IBD.ResultsDuring a median follow-up of 15.9 months, 400 of the 2,896 patients (13.8%) analyzed in this study experienced a change in diagnosis. A change in diagnosis from UC to CD, or vice-versa, was made in 24 of 1,444 patients (1.7%) and 23 of 1,452 patients (1.6%), respectively. A change to a non-IBD diagnosis was the most common modification; 7.5% (108 of 1444) and 12.7% (184 of 1452) of the patients with a referral diagnosis of UC and CD, respectively, were reclassified as having non-IBD. Among the 292 patients who were ultimately determined not to have IBD, 135 (55 UC and 80 CD cases) had received IBD-related medication.ConclusionsThere are diagnostic uncertainties and difficulties in relation to IBD. Therefore, precise assessment and systematic follow-up are essential in the management of this condition

Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA2DS2-VASc Score 0-1:A Korean Multi-Center Cohort

PURPOSE: Atrial fibrillation (AF) patients with low to intermediate risk, defined as non-gender CHA(2)DS(2)-VASc score of 0–1, are still at risk of stroke. This study verified the usefulness of ABCD score [age (≥60 years), B-type natriuretic peptide (BNP) or N-terminal pro-BNP (≥300 pg/mL), creatinine clearance (<50 mL/min/1.73 m(2)), and dimension of the left atrium (≥45 mm)] for stroke risk stratification in non-gender CHA(2)DS(2)-VASc score 0–1. MATERIALS AND METHODS: This multi-center cohort study retrospectively analyzed AF patients with non-gender CHA(2)DS(2)-VASc score 0–1. The primary endpoint was the incidence of stroke with or without antithrombotic therapy (ATT). An ABCD score was validated. RESULTS: Overall, 2694 patients [56.3±9.5 years; female, 726 (26.9%)] were followed-up for 4.0±2.8 years. The overall stroke rate was 0.84/100 person-years (P-Y), stratified as follows: 0.46/100 P-Y for an ABCD score of 0; 1.02/100 P-Y for an ABCD score ≥1. The ABCD score was superior to non-gender CHA(2)DS(2)-VASc score in the stroke risk stratification (C-index=0.618, p=0.015; net reclassification improvement=0.576, p=0.040; integrated differential improvement=0.033, p=0.066). ATT was prescribed in 2353 patients (86.5%), and the stroke rate was significantly lower in patients receiving non-vitamin K antagonist oral anticoagulant (NOAC) therapy and an ABCD score ≥1 than in those without ATT (0.44/100 P–Y vs. 1.55/100 P-Y; hazard ratio=0.26, 95% confidence interval 0.11–0.63, p=0.003). CONCLUSION: The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA(2)DS(2)-VASc score 0–1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA(2)DS(2)-VASc score 0–1

Improvement in the Tensile Bond Strength between 3Y-TZP Ceramic and Enamel by Surface Treatments

This study examined the effects of 3 mol % yttria-stabilized tetragonal zirconia polycrystal (3Y-TZP) ceramic surface treatments on the tensile bond strength and surface characteristics of enamel. To measure the tensile bond strength, the 3Y-TZP and tooth specimens were manufactured in a mini-dumbbell shape and divided into four groups based on the type of 3Y-TZP surface treatment: polishing (P), 110 µm alumina sandblasting (S), 110 µm alumina sandblasting combined with selective infiltration etching (SS), and 110 µm alumina sandblasting combined with MDP (10-methacryloyloxydecyl dihydrogen phosphate)-containing silane primer (SP). After surface treatment, the surface roughness, wettability, and surface changes were examined, and the tensile bond strength was measured. The mean values (from lowest to highest) for tensile bond strength (MPa) were as follows: P, 8.94 ± 2.30; S, 21.33 ± 2.00; SS, 26.67 ± 4.76; and SP, 31.74 ± 2.66. Compared to the P group, the mean surface roughness was significantly increased, and the mean contact angle was significantly decreased, while wettability was increased in the other groups. Therefore, surface treatment with 110 µm alumina sandblasting and MDP-containing silane primer is suitable for clinical applications, as it considerably improves the bond strength between 3Y-TZP and enamel

Retinal Hemorrhage after SARS-CoV-2 Vaccination

To report retinal vein occlusion (RVO) and age-related macular degeneration (AMD)-related submacular hemorrhage developing after administration of SARS-CoV-2 vaccines, a single-center, retrospective observational case series was conducted. Clinical data including fundus photographs and optical coherence tomography (OCT) scans were reviewed. Twenty-three eyes of 21 patients were included with the median age at symptom presentation being 77 years (range: 51–85 years). Twelve eyes (52.2%) had submacular hemorrhage and 11 (47.8%) had RVO. Twelve patients (60.9%) had been vaccinated with the Pfizer vaccine (BNT162b2) and 8 with the AstraZeneca (ChAdOx1) vaccine. Sixteen patients (76.2%) experienced ocular disease exacerbation after the first vaccination and 4 (19.0%) after the second vaccination. The median visual acuity (logarithm of the minimal angle of resolution; logMAR) before symptom development was 0.76 (interquartile range: 0.27–1.23); the median logMAR at symptom presentation was 1.40 (interquartile range 0.52–1.70). The median time between vaccination and symptom exacerbation was 2.0 days (interquartile range: 1.0–3.0 days). Five patients (23.8%) underwent tests for hematological abnormalities, including the presence of anti-PF4 antibodies; all were negative. Further studies with larger patient group for evaluation of effect of SARS-CoV-2 vaccination on retinal hemorrhage are necessary

Fabrication and Characterization of Biodegradable Gelatin Methacrylate/Biphasic Calcium Phosphate Composite Hydrogel for Bone Tissue Engineering

In the field of bone tissue, maintaining adequate mechanical strength and tissue volume is an important part. Recently, biphasic calcium phosphate (BCP) was fabricated to solve the shortcomings of hydroxyapatite (HA) and beta-tricalcium phosphate (β-TCP), and it is widely studied in the field of bone-tissue engineering. In this study, a composite hydrogel was fabricated by applying BCP to gelatin methacrylate (GelMA). It was tested by using a mechanical tester, to characterize the mechanical properties of the prepared composite hydrogel. The fabricated BCP was analyzed through FTIR and XRD. As a result, a different characteristic pattern from hydroxyapatite (HA) and beta-tricalcium phosphate (β-TCP) was observed, and it was confirmed that it was successfully bound to the hydrogel. Then, the proliferation and differentiation of preosteoblasts were checked to evaluate cell viability. The analysis results showed high cell viability and relatively high bone differentiation ability in the composite hydrogel to which BCP was applied. These features have been shown to be beneficial for bone regeneration by maintaining the volume and shape of the hydrogel. In addition, hydrogels can be advantageous for clinical use, as they can shape the structure of the material for custom applications

Production of High-Purity Tantalum Metal Powder for Capacitors Using Self-Propagating High-Temperature Synthesis

In this study, high-purity tantalum metal powder was manufactured via self-propagating high-temperature synthesis. During the process, Ta2O5 and Mg were used as the raw material powder and the reducing agent, respectively, and given that combustion rate and reaction temperature are important factors that influence the success of this process, these factors were controlled by adding an excessive mass of the reducing agent (Mg) i.e., above the chemical equivalent, rather than by using a separate diluent. It was confirmed that Ta metal powder manufactured after the process was ultimately manufactured 99.98% high purity Ta metal powder with 0.5 μm particle size. Thus, it was observed that adding the reducing reagent in excess favored the manufacture of high-purity Ta powder that can be applied in capacitors